244 related articles for article (PubMed ID: 17532199)
1. Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency.
Bernspång E; Sveger T; Piitulainen E
Respir Med; 2007 Sep; 101(9):1971-6. PubMed ID: 17532199
[TBL] [Abstract][Full Text] [Related]
2. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
Bernspång E; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2009 Jun; 103(6):861-5. PubMed ID: 19181511
[TBL] [Abstract][Full Text] [Related]
3. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
Piitulainen E; Mostafavi B; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
[TBL] [Abstract][Full Text] [Related]
4. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
[TBL] [Abstract][Full Text] [Related]
5. Alpha1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies.
Piitulainen E; Carlson J; Ohlsson K; Sveger T
Chest; 2005 Oct; 128(4):2076-81. PubMed ID: 16236857
[TBL] [Abstract][Full Text] [Related]
6. The liver in 30-year-old individuals with alpha(1)-antitrypsin deficiency.
Bernspång E; Carlson J; Piitulainen E
Scand J Gastroenterol; 2009; 44(11):1349-55. PubMed ID: 19891586
[TBL] [Abstract][Full Text] [Related]
7. CT lung densitometry in young adults with alpha-1-antitrypsin deficiency.
Bernspång E; Diaz S; Stoel B; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2011 Jan; 105(1):74-9. PubMed ID: 20674322
[TBL] [Abstract][Full Text] [Related]
8. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
[TBL] [Abstract][Full Text] [Related]
9. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
10. Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ).
Piitulainen E; Sveger T
Thorax; 2002 Aug; 57(8):705-8. PubMed ID: 12149531
[TBL] [Abstract][Full Text] [Related]
11. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
Medbø A; Melbye H
Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
[TBL] [Abstract][Full Text] [Related]
12. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
[TBL] [Abstract][Full Text] [Related]
13. Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
Piitulainen E; Montero LC; Nystedt-Düzakin M; Stoel BC; Sveger T; Wollmer P; Tanash HA; Diaz S
COPD; 2015 Apr; 12(2):162-7. PubMed ID: 25280185
[TBL] [Abstract][Full Text] [Related]
14. Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ).
Tanash HA; Nilsson PM; Nilsson JA; Piitulainen E
Thorax; 2008 Dec; 63(12):1091-5. PubMed ID: 18682522
[TBL] [Abstract][Full Text] [Related]
15. A review of alpha-1 antitrypsin deficiency.
Ranes J; Stoller JK
Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
Piitulainen E; Tanash HA
COPD; 2015 May; 12 Suppl 1():36-41. PubMed ID: 25938290
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
[TBL] [Abstract][Full Text] [Related]
18. Physician alert suggesting alpha-1 antitrypsin deficiency testing in pulmonary function test (PFT) results.
Rahaghi F; Ortega I; Rahaghi N; Oliveira E; Ramirez J; Smolley L; Stoller JK
COPD; 2009 Feb; 6(1):26-30. PubMed ID: 19229705
[TBL] [Abstract][Full Text] [Related]
19. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
[TBL] [Abstract][Full Text] [Related]
20. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.
Demeo DL; Sandhaus RA; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard S; Burchard E; Stocks JM; Stoller JK; Strange C; Turino GM; Campbell EJ; Silverman EK
Thorax; 2007 Sep; 62(9):806-13. PubMed ID: 17389752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]